prof. dr. Jan Gettemans
- Work address
-
Technologiepark-Zwijnaarde 75, FSVMII
9052 Zwijnaarde - Jan.Gettemans@UGent.be
- ORCID iD
-
0000-0001-6979-8872
Show
Sort by
-
Triazolinedione protein modification: from an overlooked off-target effect to a tryptophan-based bioconjugation strategy
-
Site-specific fluorescent labeling, single-step immunocytochemistry, and delivery of nanobodies into living cells
-
Enhanced non-toxic immunodetection of Alternaria mycotoxin tenuazonic acid based on ferritin-displayed anti-idiotypic nanobody-nanoluciferase multimers
-
- Journal Article
- A1
- open access
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells
-
- Journal Article
- A1
- open access
Transforming nanobodies into high precision tools for protein function analysis
-
- Journal Article
- A1
- open access
α-Actinin-4 promotes the progression of prostate cancer through the Akt/GSK-3β/β-catenin signaling pathway
-
- Journal Article
- A1
- open access
Development and characterization of protein kinase B/AKT isoform-specific nanobodies
-
Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging
-
Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation
-
- Journal Article
- A1
- open access
The role of gelsolin domain 3 in familial amyloidosis (Finnish type)
(2019) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 116(28). p.13958-13963